沛爾生技醫藥股份有限公司 Approved

最後更新時間 2025/09/03 , 05:40 AM
最後更新時間 2025/09/03 , 05:40 AM
負責人
Lin,Cheng-Long
統一編號
59229683
成立日期
2017/03/30
資本額
NT$1,000,000,000
實收資本額
NT$583,920,500
股票代號
6949
電話
02-87911789
地址
4F, No. 87, Sinhu 2nd Rd., Neihu Dist., Taipei City, 114, Taiwan

董監事

姓名 職稱 持有股份 代表法人
Lin,Cheng-Long Chairman 7.15% LI ZHUN INVESTMENT LTD.
Lin,Fu-Qian Director 10.27% Wistron Medical Tech Holding Company
Acer Incorporated Director 3.97%
Li,Meng-Xiu Independent Director 0.00%
You,Zhi-Qiong Independent Director 0.00%
Sun,Wei-Xin Independent Director 0.00%
Wang,Ming-Yu Independent Director 0.00%

營業項目

  • Other Professional, Scientific and Technical Activities Not Elsewhere Classified(760999)
  • Wholesale of Pharmaceutical and Medical Goods(457112)
  • 公司歷程

  • Change Capital to 1,000,000,000
    2021/10/15
  • Change Capital to 300,000,000
    2019/06/05
  • Change Capital to 200,000,000
    2017/10/17
  • Change Person in Charge to Lin,Cheng-Long
    2017/10/17
  • Change Capital to 116,000,000
    2017/09/11
  • Change Capital to 85,000,000
    2017/07/20
  • Change Capital to 50,000,000
    2017/05/12
  • 員工人數

    下載完整報告查看完整數據

    財務報表

    項目 2025 2024 2023
    Operating income 17,814 19,631 18,033
    Operating cost 16,897 31,958 44,173
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 917 -12,327 -26,140
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 917 -12,327 -26,140
    Operating expenses 168,769 401,170 385,106
    Other gain (loss), net - - -
    Operating profit (loss) -167,852 -413,497 -411,246
    Non-operating income and expenses 7,190 18,382 10,008
    Net profit (loss) before tax -160,662 -395,115 -401,238
    Income tax expense (benefits) 0 0 2
    Net profit (loss) of ongoing business for the current period -160,662 -395,115 -401,240
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period -160,662 -395,115 -401,240
    Other comprehensive profit (loss), net - - -
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period -160,662 -395,115 -401,240
    Net profit (loss) attributable to owners of parent company -153,571 -389,415 -398,756
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests -7,091 -5,700 -2,484
    Comprehensive profit (loss) attributable to owners of parent company -153,571 -389,415 -398,756
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests -7,091 -5,700 -2,484
    Basic earnings per share (yuan) -2 -6 -8
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities -123,018 -260,120 -179,990
    Net cash inflows (outflows) from investing activities 278,803 -95,508 -419,632
    Net cash inflow (outflow) from financing activities 28,333 615,318 594,894
    Effect of Exchange Rate Changes on Cash and Cash Equivalents - - -
    Increase (decrease) in cash and cash equivalents in the current period 184,118 259,690 -4,728
    Beginning balance of cash and cash equivalents 427,366 167,676 172,404
    Ending balance of cash and cash equivalents 611,484 427,366 167,676
    項目 2025 2024 2023
    Current asset 987,468 1,157,729 1,127,036
    Non-current asset 673,157 587,103 291,120
    Total asset 1,660,625 1,744,832 1,418,156
    Current liability 393,939 321,350 89,298
    Non-current liability 123,328 137,267 147,467
    Total liability 517,267 458,617 236,765
    share capital 589,171 583,946 539,426
    Equity - secruity token - - -
    capital reserve 1,816,619 1,804,039 1,449,430
    retained earning -1,360,832 -1,207,261 -817,846
    Other equity - - -
    Treasury stock -800 -800 -800
    Total equity attributable to owners of parent company 1,044,158 1,179,924 1,170,210
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 99,200 106,291 11,181
    Total Equity 1,143,358 1,286,215 1,181,391
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 262,500 276,000 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 40,000 40,000 40,000
    Net asset value per share 17 20 21

    動產抵押

    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額

    選舉收入(政治獻金)

    收入名稱 收入金額
    總收入金額

    選舉支出(政治獻金)

    支出名稱 支出金額
    總支出金額

    標案拒往

    機關名稱 生效日期 截止日期

    進出口資料

    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)

    商標

  • gm設計字
  • 生萌
  • GrowMagic
  • tcmc設計字
  • TCMC
  • PELL
  • 沛爾
  • IMPERIAL
  • 英沛爾
  • 專利

    政府標案

    標案名稱 機關名稱 決標日期 決標金額 是否得標

    裁判書查詢

    勞權違規

    日期 違反法規法條 罰鍰金額

    污染源裁處

    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。